Certified by Founder
Lodge
Ensoma
start up
United States
- Boston, MA
- 06/02/2023
- Series B
- $85,000,000
At Ensoma, we develop one-time in vivo treatments that precisely engineer any or all blood and immune cells to cure diseases from within.
- Industry Biotechnology Research
- Website https://ensoma.com/
- LinkedIn https://www.linkedin.com/company/ensomabio/people/?keywords=founder
Davis AI | $5,500,000 | (May 8, 2026)
Balcony | $12,700,000 | (May 8, 2026)
Jetty | $2,000,000 | (May 8, 2026)
ParcelBio | $13,000,000 | (May 8, 2026)
Jesse & Ben's | $10,000,000 | (May 8, 2026)
SageOx | $15,000,000 | (May 8, 2026)
CodeWords | $9,000,000 | (May 8, 2026)
Ethos | $22,750,000 | (May 8, 2026)
illoca | $13,000,000 | (May 8, 2026)
Lithosquare | $25,000,000 | (May 8, 2026)
Jurisphere.ai | $2,200,000 | (May 8, 2026)
OpsMill | $14,000,000 | (May 8, 2026)